Department of Pharmaceutical Sciences
 

News

Department of Pharmaceutical Sciences News

Dr. Logothetis Receives a $3M RO1 Grant from NIH
Dr. Logothetis Receives a $3M RO1 Grant from NIH
Please join me in congratulating Dr. Logothetis for receiving a $3M RO1 grant from NIH! The “Structural determinants of PIP2 regulation” is an NIH Heart, Lung, and Blood Institute (NHLBI) grant that was initiated in 1998 by Diomedes Logothetis and was just renewed for a 6th consecutive cycle for years 23 through 26. This ...more
June 11, 2020
Can this professor’s technology help create an army of efficient cancer killers?
Can this professor’s technology help create an army of efficient cancer killers?
Tali Konry wants to design a more effective serial killer. That may sound a little sketchy until you learn that Konry’s serial killers are immune cells, and their target is cancer. Konry, a professor of pharmaceutical sciences, is developing a technology that will address one of the most daunting challenges in cellular immunotherapy: the low success rates ...more
February 19, 2019
Looking where others have not
Looking where others have not
For decades, scientists have searched for a synthetic alternative to medical marijuana that can deliver its medicinal benefits without the harmful side effects. The problem is that the positives and negatives are tied together at the molecular level, and no one has found a way to separate them. Like a determined prospector, pharmacy professor Ganesh Thakur ...more
December 6, 2018
A new strategy for reducing opioid relapse
By Bill Ibelle, Editorial Director One of the biggest challenges in our nation’s escalating opioid epidemic is the high risk of relapse. Barbara Waszczak, Professor, School of Pharmacy Nearly 60 percent of the opioid users who seek treatment use the drug again, according to the National Institute on Drug Abuse. This is due, at least in part, to ...more
September 4, 2018